Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study
- PMID: 22108476
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study
Abstract
Aim: The aim of the present study was to evaluate the improvement of diabetic microangiopathy in patients suffering from this condition since at least five years, and whose disease was managed without insulin.
Methods: Curcumin, the orange pigment of turmeric, has recently received increasing attention because of its antioxidant properties, mediated by both direct oxygen radical quenching and by induction of anti-oxidant responses via Nrf2 activation. This aspect, combined with the beneficial effects on endothelial function and on tissue and plasma inflammatory status, makes curcumin potentially useful for the management of diabetic microangiopathy. To further evaluate this, Meriva, a lecithinized formulation of curcumin, was administered at the dosage of two tablets/day (1 g Meriva/day) to 25 diabetic patients for four weeks. A comparable group of subjects followed the best possible management for this type of patients.
Results: All subjects in the treatment and control group completed the follow-up period; there were no dropouts. In the treatment group, at four weeks, microcirculatory and clinical evaluations indicated a decrease in skin flux (P<0.05) at the surface of the foot, a finding diagnostic of an improvement in microangiopathy, the flux being generally increased in patients affected by diabetic microangiopathy. Also, a significant decrease in the edema score (P<0.05) and a corresponding improvement in the venoarteriolar response (P<0.05) were observed. The PO2 increased at four weeks (P<0.05), as expected from a better oxygen diffusion into the skin due to the decreased edema. These findings were present in all subjects using Meriva, while no clinical or microcirculatory effects were observed in the control group.
Conclusion: Meriva was, in general, well tolerated, and these preliminary findings suggest the usefulness of this curcumin formulation for the management of diabetic microangiopathy, opening a window of opportunities to be evaluated in more prolonged and larger studies. The molecular mechanisms involved in the beneficial effects of curcumin on microcirculation and edema are also worth investigation.
Similar articles
-
Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy.Panminerva Med. 2012 Dec;54(1 Suppl 4):11-6. Panminerva Med. 2012. PMID: 23241930 Clinical Trial.
-
Treatment of diabetic microangiopathy and edema with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled randomized study.Angiology. 2001 Oct;52 Suppl 2:S27-31. Angiology. 2001. PMID: 11666119 Clinical Trial.
-
Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study.Panminerva Med. 2012 Dec;54(1 Suppl 4):17-22. Panminerva Med. 2012. PMID: 23241931 Clinical Trial.
-
The emerging role of curcumin for improving vascular dysfunction: A review.Crit Rev Food Sci Nutr. 2018;58(16):2790-2799. doi: 10.1080/10408398.2017.1341865. Epub 2017 Aug 21. Crit Rev Food Sci Nutr. 2018. PMID: 28662351 Review.
-
Exercise and diabetic microangiopathy.Diabetes. 1979 Jan;28 Suppl 1:103-6. doi: 10.2337/diab.28.1.s103. Diabetes. 1979. PMID: 367850 Review. No abstract available.
Cited by 21 articles
-
Protective role of NRF2 in macrovascular complications of diabetes.J Cell Mol Med. 2020 Jul 6;24(16):8903-17. doi: 10.1111/jcmm.15583. Online ahead of print. J Cell Mol Med. 2020. PMID: 32628815 Free PMC article. Review.
-
Biochemistry, Safety, Pharmacological Activities, and Clinical Applications of Turmeric: A Mechanistic Review.Evid Based Complement Alternat Med. 2020 May 10;2020:7656919. doi: 10.1155/2020/7656919. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32454872 Free PMC article. Review.
-
Antidiabetic Properties of Curcumin II: Evidence from In Vivo Studies.Nutrients. 2019 Dec 25;12(1):58. doi: 10.3390/nu12010058. Nutrients. 2019. PMID: 31881654 Free PMC article. Review.
-
Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.J Pharmacol Exp Ther. 2019 Dec;371(3):642-651. doi: 10.1124/jpet.119.261792. Epub 2019 Oct 10. J Pharmacol Exp Ther. 2019. PMID: 31601682
-
Curcumin C3 complex®/Bioperine® has antineoplastic activity in mesothelioma: an in vitro and in vivo analysis.J Exp Clin Cancer Res. 2019 Aug 16;38(1):360. doi: 10.1186/s13046-019-1368-8. J Exp Clin Cancer Res. 2019. PMID: 31419989 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources